SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Theragenics (TGX) on the up and up
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: sport who wrote (997)7/21/1998 1:08:00 PM
From: Tulvio Durand  Read Replies (2) of 1055
 
Well stated, Sport, and I share those same sentiments. An opportunity was blown to showcase the company's accomplishments and prospects. For example, a hopeful word about third Q earnings would have helped. Market's reaction is telling -- THRX is up 2% while competitor NASI, up 10%, is raining on THRX's parade. It would appear that, at a minimum, PR is not THRX's strong suit. Perhaps there are more negatives here that Jacobs didn't want to dwell on. Perhaps Jacobs is worried that NASI will produce the same Pd 103 seeds at 1/3 THRX's cost. Perhaps -- etc., etc. But, in spite of these real/imagined demons, I will suffer as stockholder for one more Q. Tulvio
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News